Washington [US], June 17 (ANI): The US Food and Drug Administration (FDA) authorized emergency use of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include use in children down to 6 months of age.
California [US], February 14 (ANI): The majority of the vaccines available for COVID-19 have two doses. People are said to become more capable of resisting the virus after the second dose. But, a recent Kaiser Permanente study, found that one month after a third dose, the effectiveness of th
New York [US], February 2 (ANI): The pharmaceutical companies, Pfizer and BioNTech, are seeking Emergency Use Authorization for their COVID-19 vaccine for use in children between six months and four years of age.
Madrid [Spain], December 28 (ANI/Xinhua): The Spanish Ministry of Health on Monday evening said that the 14-day incidence of the coronavirus rose by 294 points in the four days from December 23 to 1,206.21 cases per 100,000 people after the Christmas holiday weekend.
Washington [US], December 16 (ANI): White House Chief Medical advisor Antony Fauci on Wednesday said that the currently available booster shots work against the Omicron variant of Covid-19 and there is no need for a variant-specific booster.
New York [US]/Mainz [Germany], December 9 (ANI): A preliminary laboratory study demonstrated that three doses of the Pfizer-BioNTech COVID-19 vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers.
London [UK], November 28 (ANI): A new research has discovered a gradual increase in the risk of COVID-19 infection from 90 days after receiving a second dose of the Pfizer-BioNTech vaccine.
Washington [US], November 27 (ANI): The pharmaceutical companies Pfizer and BioNTech on Saturday issued a statement stating that they are not sure whether their vaccines would be able to help in the treatment of the new COVID-19 variant 'Omicron'.
London [UK], November 25 (ANI): A new study has found a gradual increase in the risk of COVID-19 infection from 90 days after receiving a second dose of the Pfizer-BioNTech vaccine.
Washington [US], November 10 (ANI/Sputnik): Pharmaceutical companies Pfizer and BioNTech have filed an application with the Japanese Ministry of Health, Labour and Welfare for approval of their COVID-19 vaccine for children aged five to 11, according to a statement released on Wednesday.
London [UK], November 8 (ANI/Xinhua): Another 30,305 people in Britain have tested positive for COVID-19, bringing the total number of coronavirus cases in the country to 9,301,909, according to official figures released Sunday.
Washington [US], October 26 (ANI/Xinhua): Advisors to the U.S. Food and Drug Administration (FDA) are set for a key meeting Tuesday on whether to recommend the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, as experts predicted younger kids will be eligible for the vaccine in e